Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
GlobeNewswire, Inc.
First-in-class CEACAM5-targeting ADC armed with a pan-RAS(ON) inhibitor – designed for tumor-selective RAS pathway inhibition First patient dosed in Australia; global Phase I initiated U.S. FDA cleared IND with "Study-May-Proceed" letter SINGAPORE...
Bone Biologics Expands Trial Sites
GlobeNewswire, Inc.
BURLINGTON, MA, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for spine fusion markets, today announced that six hospital sites in...
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
GlobeNewswire, Inc.
AUSTIN, Texas, Sept. 08, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients back what they have already...
AirNexis Therapeutics Announces that AN01, a Dual PDE3/4 Inhibitor Dry Powder Inhaler (DPI) Met its Primary Endpoint in a Phase 2b COPD Study (HSK39004-T1-202) Conducted in China by AirNexis' partner Haisco Pharmaceutical Group
GlobeNewswire, Inc.
Phase 2b dose ranging data presented at ERS show both doses of AN01 delivered significant and clinically relevant improvements in lung function versus placebo at Week 4 Trial comprised of broad COPD population, including participants on background...
Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
GlobeNewswire, Inc.
RAMAT GAN, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases,...
BrewDog Roars into Rugby with Five-Year Leicester Tigers Partnership, Bringing Punk Energy to Welford Road
GlobeNewswire, Inc.
ELLON, Scotland and LONDON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- BrewDog, a leader in U.K. craft beer and one of the world’s most recognised craft beer brands, by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), today announced a five-year partnership...
Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program
GlobeNewswire, Inc.
MILAN and MORRISTOWN, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Newron Pharmaceuticals S.p.A. (“Newron”, or the “Company”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases...
Rapid Nutrition Reports 227.5% H1 Revenue Growth as Group Enters Transformational Second Half
GlobeNewswire, Inc.
LONDON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Rapid Nutrition PLC (Euronext Growth: ALRPD), a HealthTech and wellness company focused on evidence-based nutrition, personalised wellness and technology-enabled consumer engagement, is pleased to...
Cryogenic Equipment Market to Reach USD 54.06 Billion by 2035, Driven by LNG Expansion and Hydrogen Economy
EIN Presswire
Liquid Oxygen accounts for approximately USD 5.8 billion in 2025, sustained by healthcare and steelmaking applications.
2026 AUSTRALIAN MUSEUM EUREKA PRIZES WINNERS ANNOUNCED
EIN Presswire
More than 500 guests attend the glittering ceremony at Sydney Town Hall to celebrate 19 winners of the 2026 Australian Museum Eureka Prizes SYDNEY, AUSTRALIA, September 4, 2026 /EINPresswire.com/ -- A marine heatwave forecasting system, a solar...
Medical Foam Market to Reach USD 49.51 Billion by 2031 as Advanced Wound Care Fuels Growth, Says Mordor Intelligence
EIN Presswire
Medical Foam Market to register a CAGR of 7.08% during 2026–2031, with North America leading the global market.
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
GlobeNewswire, Inc.
MELBOURNE, Australia and SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for...
Cosmos Health: A Company Transformed — 2026 Year-to-Date
GlobeNewswire, Inc.
A Comprehensive Corporate Summary — January 1, 2026 through August 31, 2026 Revenue record set three consecutive quarters: FY2025 $65.3M (+20%) → Q1 2026 $17.93M (+31%) → Q2 2026 $18.99M (+28.8%) → H1 2026 $36.91M (+29.7%). Annualized adjusted...
Health-ISAC® Invests in APAC with Key Staff Addition in Australia
GlobeNewswire, Inc.
MELBOURNE, Australia, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Health Information Sharing and Analysis Center (Health-ISAC) announces the hiring of Simon Cowley as the new Asia Pacific (APAC) Health Sector Security & Partnerships Manager, effective...
Lifter Unveils Digital Advertising Playbook for Navigating Men’s Sexual Health Categories
EIN Presswire
Canadian healthcare marketing agency outlines a practical framework for clinics facing evolving platform policies and healthcare advertising requirements.
Advantage Healthcare & Physiotherapy, Marks 22 Years Providing Physiotherapy in Wynnum
EIN Presswire
Wynnum physio clinic reflects on more than two decades of supporting the Brisbane Bayside community through experienced allied health care.
AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference
GlobeNewswire, Inc.
VALENCIA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that its senior management will participate in...
Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
GlobeNewswire, Inc.
Nutriband has received a Notice of Publication from the United States Patent and Trademark Office (USPTO) for commercial brand name trademarks for its lead product, an abuse deterrent fentanyl transdermal system.
Ranchbot Joins U.S. Roundtable for Sustainable Beef
EIN Presswire
Remote water monitoring company brings ranch-level data and infrastructure expertise to national beef sustainability initiative FORT WORTH, TX, UNITED STATES, September 8, 2026 /EINPresswire.com/ -- Ranchbot Monitoring Solutions, a ranching...
eLeaP QMS Delivers Purpose-Built Support for ISO 13485:2016 Medical Device Manufacturers
EIN Presswire
eLeaP QMS gives medical device manufacturers the document control, design control, CAPA, and traceability tools needed to meet ISO 13485 requirements.
Sign up for:
Australian Healthcare Herald
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.